By David Tuller, DrPH Two months ago, Clinical Infectious Diseases (CID), a high-impact journal, published a study called “Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results…
…Disease 2019: Results of a Randomized Controlled Trial.” The study, nick-named ReCOVer, found that unblinded trials relying on subjective outcomes will produce modestly positive reports in the group receiving the…
…came out last month, was co-authored by four British physiotherapists—Karen Leslie, Dr Michelle Bull, Dr Nicola Clague-Baker, and Natalie Hilliard. In 2019, the four of them founded an organization, Physios…
…a new Center for Infection & Immunity. She was elected to the National Academy of Sciences in 2018, the National Academy of Medicine in 2019, to and the American Academy…
…Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial,” nicknamed ReCOVer, was published in Clinical Infectious Diseases, a well-regarded journal, and proclaimed itself a success….
…called “Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID.” In 2019, I’d physically attended a similar NIH gathering; this time, I caught many of the presentations…
